Ethical issues in clinical neuroscience research: a patient's perspective

Area of Science:

• Neuroscience
• Clinical Research
• Patient Advocacy

Background:

• Declining innovation, increasing costs, and lengthy development times hinder new therapy pipelines.
• Divergent values among stakeholders (scientists, clinicians, industry, patients) create ethical conflicts and erode public trust in medical research.
• Parkinson's disease patients possess unique perspectives on clinical trial participation, risks, benefits, and ethical considerations.

Purpose of the Study:

• To present a patient-centered paradigm for clinical research and medical care.
• To analyze ethical conflicts and loss of public confidence in neurotherapeutics research.
• To integrate authentic patient voices into all stages of therapy development.

Main Methods:

• Analysis of stakeholder values and motivations in neurotherapeutics.
• Presentation of Parkinson's advocates' views on clinical trial participation, placebo controls, and sham surgery.
• Incorporation of adaptive clinical trial methods and health information technology for outcome assessment and safety surveillance.

Main Results:

• A patient-centered paradigm can resolve conflicts, build trust, enhance trial recruitment, and expedite new therapies.
• The Parkinson Pipeline Project exemplifies patient collaboration and advocacy in treatment development.
• Informed patients, connected globally, are becoming active participants in research.

Conclusions:

• Authentic patient collaboration is crucial for overcoming challenges in clinical research and medical care.
• Implementing adaptive trials and advanced IT can improve the lifecycle assessment of medical products.
• Patient-centered research fosters trust and accelerates the delivery of innovative neurotherapies.